The store will not work correctly when cookies are disabled.
2-(4-Phenoxybutanamido)thiazole-5-carboxylic acid
ID: ALA4538493
PubChem CID: 155549469
Max Phase: Preclinical
Molecular Formula: C14H14N2O4S
Molecular Weight: 306.34
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(CCCOc1ccccc1)Nc1ncc(C(=O)O)s1
Standard InChI: InChI=1S/C14H14N2O4S/c17-12(16-14-15-9-11(21-14)13(18)19)7-4-8-20-10-5-2-1-3-6-10/h1-3,5-6,9H,4,7-8H2,(H,18,19)(H,15,16,17)
Standard InChI Key: KPEFYSJGGSTAON-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 22 0 0 0 0 0 0 0 0999 V2000
40.7137 -4.7380 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7125 -5.5576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4206 -5.9665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1303 -5.5571 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
42.1274 -4.7344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4188 -4.3292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0059 -4.3296 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.2983 -4.7384 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.5905 -4.3299 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.8829 -4.7387 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1751 -4.3303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4674 -4.7390 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.1749 -3.5131 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.7596 -4.3306 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.6729 -3.5195 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
34.8735 -3.3498 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4651 -4.0577 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0121 -4.6647 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.5410 -2.6034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0212 -1.9421 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.7282 -2.5181 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
1 7 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
11 13 2 0
12 14 1 0
14 15 1 0
15 16 1 0
16 17 2 0
17 18 1 0
18 14 2 0
16 19 1 0
19 20 2 0
19 21 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 306.34 | Molecular Weight (Monoisotopic): 306.0674 | AlogP: 2.64 | #Rotatable Bonds: 7 |
Polar Surface Area: 88.52 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.21 | CX Basic pKa: ┄ | CX LogP: 2.39 | CX LogD: -1.13 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.77 | Np Likeness Score: -1.60 |
References
1. Nguyen W, Jacobson J, Jarman KE, Jousset Sabroux H, Harty L, McMahon J, Lewin SR, Purcell DF, Sleebs BE.. (2019) Identification of 5-Substituted 2-Acylaminothiazoles That Activate Tat-Mediated Transcription in HIV-1 Latency Models., 62 (10): [PMID:30973727] [10.1021/acs.jmedchem.9b00462] |